Supplementary Methods
Cell culture DES, EES, and NEES were isolated as previously described. [1] [2] [3] [4] [5] The endometrial and endometriotic tissues were carefully dissected and minced into 1-2 mm3 fragments incubated in phenol red-free DMEM/F-12 containing type I collagenase (0.25%) (Life Technologies) and deoxynuclease I (15 U/mL) containing 10% charcoal-stripped fetal bovine serum (FBS) (Sigma-Aldrich, Lyon, France), 100 U/mL penicillin (Sigma-Aldrich), 0.1 mg/mL streptomycin (Sigma-Aldrich), and 0.25 µg/mL amphotericin B (Sigma-Aldrich) and incubated at 37 °C in 95% air/5% CO2. Cells at passage 1 were used for experiments. The numbers of samples of DES, EES, and/or NEES used for each experiment are summarized in Supplementary Table S3 online.
Immunofluorescence staining was performed to determine the purity of the isolated EES, NEES and DES using monoclonal antibodies for human cytokeratin (a marker of epithelial cells) (MNF116, 6, 7 factor VIII (a marker of endothelial cells) (1:100, DAKO), and CD45 (a marker of bone marrow-derived cells) (1:100, DAKO), as previously described. [1] [2] [3] [4] [5] The results indicated that the purity of stromal cells was >99% (data not shown).
Preparation of stiffness-controlled 96-well plates
Stiffness-controlled 96-well plates were prepared using modifications to the protocol of Syed et al. 8 Briefly, to produce the desired gels of variable stiffness (2 or 30 kPa), polyacrylamide gel precursor solution was prepared by mixing acrylamide (Bio-Rad Laboratories, Hercules, CA, USA), bis-acrylamide (Bio-Rad), 1 M HEPES (Sigma-Aldrich), and double-distilled H2O. The gel solution was pipetted onto the hydrophilic side of the flexible plastic support (GelBond PAG Gel Film, GE Healthcare Buckinghamshire, UK) and sandwiched with hydrophobic-coated glass slides. The polyacrylamide gel was then polymerized and dried onto the flexible plastic support. Then, the polyacrylamide gels were cut using a heavy-duty hole punch with a diameter of 6 mm for a 96-well plate. To glue the gels to the bottom of the 96-well plates, 5 μL of polydimethylsiloxane (PDMS, Sigma-Aldrich) were placed in the center of each well.
Then, one polyacrylamide gel was placed in each well. To allow the PDMS to cure, the assembled 96-well plate was left at 37 °C for 4 h. Then, the polyacrylamide gel was activated with sulfo-SANPAH (Thermo Scientific, Illkirch, France) to cross-link the ECM protein (collagen) to the polyacrylamide gel surface.
The polyacrylamide gel was coated with type I collagen (0.2 mg/mL) (BD Biosciences) overnight at 4 °C.
The gels were sterilized under UV light (λ=200 nm) for 2 h. Then, the gels were soaked in complete medium overnight to hydrate and equilibrate. Cells were grown on polyacrylamide gel substrates (PGS) of varying stiffness (2 or 30 kPa) or plastic.
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Percent cell proliferation is calculated relative to vehicle-treated cells.
Supplementary Figure 2: Effects of combined treatment with U0126 and MK2206 on cell proliferation in EES versus endometrial stromal cells without endometriosis (NEES). (A): EES-P (n=10) versus NEES-P (n=5). (B): EES-S (n=6) versus NEES-S (n=5). (C): EES-M (n=5) versus NEES-M (n=5).
Dose 1: U0126 (15 µM) and MK2206 (4.5 µM). (A): EES-P (n=10) versus NEES-P (n=5).
(B): EES-S (n=6) versus NEES-S (n=5). (C): EES-M (n=5) versus NEES-M (n=5).
Cells were grown on PGS of varying stiffness (2 or 30 kPa) or plastic. 
